IL10 and myeloid sarcoma: Stewart et al. [23] observed that untreated MS (relapsing/remitting) cases showed a summer excess of interleukin-10, and Balashov et al. [24] reported a significantly increased interferon production in the autumn and winter compared to the spring and summer in chronic progressive MS, with maximum values of T-cell activation (assessed in terms of tumor necrosis factor and interferon levels) found during autumn by Killestein et al. [25].